|
Cytokine-cytokine receptor interaction
|
29 |
2.31E-21 |
| Rheumatoid arthritis |
11 |
1.52E-08 |
|
Toll-like receptor signaling pathway
|
9 |
5.96E-06 |
| Chagas disease (American trypanosomiasis) |
8 |
5.22E-05 |
| Amoebiasis |
8 |
5.22E-05 |
|
Jak-STAT signaling pathway
|
9 |
8.16E-05 |
| Cytosolic DNA-sensing pathway |
6 |
8.16E-05 |
| NOD-like receptor signaling pathway |
6 |
8.16E-05 |
| Chemokine signaling pathway |
9 |
0.0003 |
| Focal adhesion |
9 |
0.0004 |
| ECM-receptor interaction |
6 |
0.0004 |
| Allograft rejection |
4 |
0.0011 |
| Type I diabetes mellitus |
4 |
0.0021 |
| Intestinal immune network for IgA production |
4 |
0.0032 |
| Toxoplasmosis |
6 |
0.0033 |
| Hematopoietic cell lineage |
5 |
0.0033 |
| Malaria |
4 |
0.0033 |
| Small cell lung cancer |
5 |
0.0033 |
| Pathogenic Escherichia coli infection |
4 |
0.0038 |
| Phagosome |
6 |
0.0061 |
| African trypanosomiasis |
3 |
0.0082 |
| RIG-I-like receptor signaling pathway |
4 |
0.0082 |
